SEC Form 4 · accession 0001144204-16-082395
Zynerba Pharmaceuticals, Inc. · ZYNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Rapp
10% Owner
Period of report
Feb 2, 2016
Accepted (ET)
Feb 16, 2016 · 2:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001621443
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 2, 2016 | J | 80,467 | — | A | 1,344,115 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Broadband Capital Management LLC ("BCM") transferred 80,467 shares held by it to Reporting Person for no consideration. The Reporting Person is the Chairman and member of BCM.